Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1911INDUSTRY 1292NIH 180NETWORK 65OTHER_GOV 38UNKNOWN 6FED 6INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 8Barrett Esophagus 5Myasthenia Gravis 4Breast Neoplasms 4Leiomyoma 3Carcinoma, Hepatocellular 3Pancreatic Neoplasms 2Multiple Myeloma 2Lymphoma, Follicular 2Lung Neoplasms 2Lipoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma in Situ 2Warts 1Vaginosis, Bacterial 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Syphilis 1Sexually Transmitted Diseases 1Retroperitoneal liposarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pilonidal Sinus 1Papillomavirus Infections 1Overweight 1Ovarian Neoplasms 1Osteosarcoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Neoplasm Metastasis × Clear all
NCT00378638 2007-10-24

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Chap, Linnea I., M.D.

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡